Shares of Ocugen Inc. /zigman2/quotes/208160861/composite OCGN +1.22% slipped 5.90% to $8.30 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.28% falling 0.00% to 4,682.80 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.29% falling 0.04% to 36,087.45. The stock's fall snapped a two-day winning streak. Ocugen Inc. closed $10.47 below its 52-week high ($18.77), which the company achieved on February 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Adverum Biotechnologies Inc. /zigman2/quotes/210484271/composite ADVM +2.58% fell 1.36% to $2.17, Ocular Therapeutix Inc. /zigman2/quotes/207607068/composite OCUL +2.91% rose 1.58% to $7.08, and Kodiak Sciences Inc. /zigman2/quotes/207655028/composite KOD +7.44% fell 6.90% to $104.58. Trading volume (11.6 M) remained 26.1 million below its 50-day average volume of 37.7 M.